"Overcoming the regulatory challenges faced by impurities: An immunogenicity perspective"
2-3 April 2012, London, UK
"Overcoming the regulatory challenges faced by impurities: An immunogenicity perspective"
22-23 November in Berlin
“Alipogene tiparvovec reduces the risk of pancreatitis in lipoprotein lipase deficient patients”
Brighton, United Kingdom